Novartis has stockpiles to withstand potential Trump tariffs, CEO says
PositiveFinancial Markets

Novartis CEO has reassured investors that the company is well-prepared to handle any potential tariffs imposed by the Trump administration. This proactive approach highlights Novartis's strong financial position and strategic planning, which is crucial for maintaining stability in the pharmaceutical market. Such readiness not only protects the company's interests but also ensures continued access to essential medications for patients.
— Curated by the World Pulse Now AI Editorial System